Integrative recombination of bacteriophage lambda: requirement for supertwisted DNA in vivo and characterization of int.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D010582:Bacteriophage lambda / Q000235:genetics*; D001665:Binding Sites; D003374:Coumarins / Q000494:pharmacology; D004250:DNA Topoisomerases, Type II / Q000378:metabolism; D004269:DNA, Bacterial / Q000235:genetics; D004278:DNA, Superhelical / Q000235:genetics*; D004279:DNA, Viral / Q000235:genetics; D005809:Genes, Regulator; D008242:Lysogeny / Q000187:drug effects; D011758:Pyrroles / Q000494:pharmacology; D011995:Recombination, Genetic / Q000187:drug effects; D014764:Viral Proteins / Q000235:genetics
D000900:Anti-Bacterial Agents; D003374:Coumarins; D004269:DNA, Bacterial; D004278:DNA, Superhelical; D004279:DNA, Viral; D011758:Pyrroles; D014764:Viral Proteins; D004250:DNA Topoisomerases, Type II